ALPHA9 ONCOLOGY Trademark

Trademark Overview


On Friday, November 22, 2024, a trademark application was filed for ALPHA9 ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the ALPHA9 ONCOLOGY trademark a serial number of 98867920. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, July 28, 2025. This trademark is owned by Alpha-9 Oncology Inc.. The ALPHA9 ONCOLOGY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals and preparations, namely, radiodiagnostics and radiotherapeutics and their preparations, for the diagnosis and treatment of cancer

Medical services in the field of nuclear medicine and medical imaging and treatment of cancer by use of targeted delivery of a radionuclide

Development of medical products in the field of nuclear medicine
alpha9 oncology

General Information


Serial Number98867920
Word MarkALPHA9 ONCOLOGY
Filing DateFriday, November 22, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, July 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized word "ALPHA" in blue with the letter "H" & the second letter "A" partially orange followed by the number "9" in blue, and the word "ONCOLOGY" in orange.
Goods and ServicesPharmaceuticals and preparations, namely, radiodiagnostics and radiotherapeutics and their preparations, for the diagnosis and treatment of cancer
Pseudo MarkALPHA NINE ONCOLOGY
Indication of Colors claimedThe color(s) blue and orange is/are claimed as a feature of the mark.
Goods and ServicesMedical services in the field of nuclear medicine and medical imaging and treatment of cancer by use of targeted delivery of a radionuclide
NOT AVAILABLEONCOLOGY
Goods and ServicesDevelopment of medical products in the field of nuclear medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 22, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlpha-9 Oncology Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, British Columbia V5T1M4
CA

Trademark Events


Event DateEvent Description
Friday, November 22, 2024NEW APPLICATION ENTERED
Thursday, May 15, 2025ASSIGNED TO EXAMINER
Friday, May 30, 2025NON-FINAL ACTION WRITTEN
Friday, May 30, 2025NON-FINAL ACTION E-MAILED
Friday, May 30, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED